Abstract
The CDC Advisory Committee on Immunization Practices (ACIP) has recently recommended influenza vaccination for many high-risk groups, including patients with hemoglobinopathies; patients receiving long-term salicylate therapy; and patients with cardiac, pulmonary, metabolic, and renal diseases (MMWR …
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
